Prestige Brands Holdings (NYSE: PBH) is paying $750 million for private equity-backed Insight Pharmaceuticals, the maker of home pregnancy test product EPT.

Insight Pharmaceuticals, headquartered in Revose, Pa., sells over-the-counter products, including women's health and personal-care products such as Monistat.

Tarrytown, N.Y.-based Prestige Brands owns several over the counter products, including Beano and Dramamine, plus household cleaners and other care products.

Swander Pace Capital has owned Insight since 2009, when the company's sales were about $79 million. Now, according to Swander Pace, Insight's sales exceed $200 million.

The San Francisco-based private equity firm focuses on investments in consumer products companies. In March, it announced an exit from Pineridge Bakery, which it sold to Aryzta AGfor $340 million. In January, the firm invested in Aden + Anais, a baby products company. 

Michelle Moore and Seth Hemming from Reed Smith LLP advised Prestige on the aqquisition. Kirkland & Ellis LLP was Swander Pace's legal counsel on the deal. 


Subscribe Now

Complete access to real-time information and analysis of news and trends in the industry.

14-Day Free Trial

No credit card required. Complete access to articles, breaking news and industry data.